According to the World Health Organization 2011 World Malaria Report, the estimated number of global malaria deaths has fallen from about 985,000 in 2000 to approximately 655,000 in 2010. In spite of this progress, malaria remains one of the major public health problems on the African continent, and the goal of the President’s Malaria Initiative (PMI) is to significantly reduce this burden. PMI assists 19 focus countries in Africa and one regional program in the Greater Mekong Sub-region of southeast Asia. In Africa, PMI supports countries to increase access to four proven malaria prevention and treatment measures: insecticide-treated mosquito nets (ITNs), indoor residual spraying with insecticides (IRS), intermittent preventive treatment for pregnant women, and improved laboratory diagnosis and appropriate treatment, including artemisinin-based combination therapies. In the Greater Mekong Sub-region, PMI support includes regional/cross-cutting activities such as surveillance for antimalarial drug resistance and antimalarial drug quality monitoring.
The material presented here is also available in an easily printable format [PDF, 433KB].
How is the target measured? |
Learn more specific information on measurement and data limitations.
What are the U.S. Government-supported countries? |
Countries receive funding based, in part, on an analysis of need (both the severity of the health problem and the number of people affected by the health problem) and the U.S. Government’s ability to affect health program.
Click here or above for a larger version and country list. |
What are the results? |
PMI continues to project a significant increase in the number of people reached with malaria prevention measures, despite only a slight increase in budget. Programs have been initiated and scaled up in both the Democratic Republic of the Congo and Nigeria, as targeted. Through all its country programs, PMI has reached nearly 130 million people with a prevention measure (insecticide treated nets and/or indoor residual spraying). In fiscal year (FY) 2011 alone, PMI protected 58 million individuals from malaria and expects to increase its annual reach to 75 million by FY 2013 with U.S. Government funds. Additionally in FY 2011, PMI distributed more than 30 million treatments of life-saving drugs to the targeted population.
Dramatic increases in the coverage of malaria control measures are now being documented in nationwide household surveys as a result of the contributions of PMI, prior U.S. Government assistance, host country governments, and other donors. In 11 PMI-supported countries with baseline and follow-up nationwide household surveys (Angola, Ethiopia, Ghana, Kenya, Madagascar, Malawi, Rwanda, Senegal, Tanzania, Uganda, and Zambia), substantial reductions in all-cause mortality (ranging from 16 to 50 percent) have been documented in children under the age of five. This is more fully detailed in the recent PMI report.
Source of data: PMI Program Reports, based on U.S. Government Fiscal Year (Oct. 1–Sept. 30) |